Retour sur lavenir.net
   NYXOAH 1.420 € (+1,43 %)     CMB.TECH 12.560 € (+1,13 %)     UCB 251.300 € (+0,84 %)     OPTION 5.740 € (-8,60 %)     AZELIS GROUP 9.820 € (+0,20 %)     XIOR 25.900 € (-0,38 %)     AB INBEV 71.120 € (+0,99 %)     EVS 29.500 € (-0,34 %)     SOLVAY 27.940 € (+0,50 %)     AGEAS 66.950 € (-0,37 %)     UMICORE 23.640 € (-0,34 %)     D'IETEREN GROUP 163.000 € (-1,21 %)     WDP 21.600 € (-0,64 %)     ARGENX SE 770.600 € (+1,02 %)     IBA 16.380 € (+1,74 %)     KBC ANCORA 82.000 € (+0,24 %)     GBL 79.350 € (+0,06 %)     COLRUYT 34.280 € (+0,47 %)     SOFINA 221.200 € (-0,09 %)     KBC 119.350 € (+0,25 %)     SYENSQO 68.000 € (+0,59 %)     MELEXIS 82.900 € (-0,12 %)     CENERGY 24.700 € (-1,12 %)     OXURION 0.004 € (0,00 %)     DEME GROUP 181.000 € (-0,44 %)     AEDIFICA 67.050 € (-1,32 %)     FLUXYS BELGIUM D 19.600 € (-0,25 %)     KINEPOLIS GROUP 35.200 € (-0,71 %)     PROXIMUS 6.165 € (0,00 %)     RECTICEL 11.060 € (+1,84 %)     TESSENDERLO 20.500 € (-0,49 %)     TUBIZE-FIN 220.400 € (+1,01 %)     SIPEF 92.400 € (-0,11 %)     CARE PROPERTY INV. 12.400 € (-0,32 %)     LOTUS BAKERIES 11 180.000 € (-0,71 %)     MONTEA 65.600 € (-0,46 %)     TINC 11.620 € (-0,17 %)     ELIA GROUP 130.600 € (-0,84 %)     BANQUP GROUP 2.910 € (+23,31 %)     BREDERODE 102.000 € (-0,39 %)     TITAN S.A. 54.000 € (-0,55 %)     BPOST 1.622 € (+0,37 %)     ACKERMANS V.HAAREN 285.400 € (-0,83 %)     ASCENCIO 51.500 € (-0,39 %)     BARCO 8.630 € (-0,69 %)     VGP 82.200 € (-0,24 %)     EKOPAK 3.980 € (+1,27 %)     GIMV 44.550 € (-0,22 %)     SOLVAC NOM(RETAIL) 76.000 € (-1,94 %)     ONWARD MEDICAL 2.670 € (+0,38 %)     RETAIL ESTATES 68.500 € (-0,58 %)     ONTEX GROUP 2.435 € (+0,21 %)     HOME INVEST BE. 19.400 € (0,00 %)     FAGRON 23.800 € (+0,21 %)     CELYAD ONCOLOGY 0.256 € (-4,12 %)     HYLORIS 4.640 € (+0,87 %)     WERELDHAVE BELGIUM 52.400 € (+0,38 %)     HYBRID SOFTWARE GR 4.060 € (0,00 %)     COFINIMMO 79.000 € (-0,82 %)     QRF 11.150 € (0,00 %)  
   VIRIDIEN 91.350 € (+1,33 %)     LLAMA GROUP 0.380 € (-1,43 %)     OPMOBILITY 14.180 € (-0,35 %)     CVC CAPITAL 13.060 € (+0,15 %)     STIF 59.000 € (0,00 %)     EXOSENS 60.150 € (+1,01 %)     STELLANTIS NV 5.638 € (+1,22 %)     AIRBUS 191.840 € (-0,05 %)     BNP PARIBAS ACT.A 100.720 € (-0,38 %)     SAFRAN 334.300 € (+0,24 %)     SOPRA STERIA GROUP 143.500 € (+0,35 %)     ASML HOLDING 1 645.200 € (-1,84 %)     GTT 193.700 € (+0,73 %)     RENAULT 27.730 € (+2,59 %)     NX FILTRATION 3.230 € (-1,07 %)     FDJ UNITED 22.400 € (-0,58 %)     THX PHARMA 3.440 € (-1,43 %)     VEOLIA ENVIRON. 35.870 € (-0,22 %)     ING GROEP N.V. 27.590 € (+0,24 %)     TOTALENERGIES 71.040 € (+1,00 %)     ARKEMA 57.850 € (+0,43 %)     REXEL 38.580 € (+0,03 %)     MAGNUM 14.302 € (-1,85 %)     ESSILORLUXOTTICA 176.700 € (-0,51 %)     PROSUS 39.075 € (-0,04 %)     IMCD 83.040 € (-1,03 %)     SANOFI 74.900 € (+2,13 %)     BE SEMICONDUCTOR 315.100 € (-0,85 %)     HEINEKEN 70.500 € (-0,34 %)     SES 7.110 € (0,00 %)     HAL TRUST 163.800 € (-0,24 %)     UBISOFT ENTERTAIN 5.204 € (+2,64 %)     RELX 27.480 € (+0,96 %)     AHOLD DEL 34.870 € (+1,01 %)     THERMADOR GROUPE 68.800 € (-0,72 %)     L'OREAL 383.450 € (-1,05 %)     UMG 18.740 € (+0,21 %)     CAPGEMINI 89.120 € (+0,13 %)     ABC ARBITRAGE 5.290 € (+0,19 %)     ABN AMRO BANK N.V. 37.410 € (-0,45 %)     KALRAY 9.240 € (-0,22 %)     TRIGANO 135.500 € (-0,51 %)     FUGRO 11.030 € (-0,72 %)     ABIONYX PHARMA 2.190 € (-2,23 %)     SHELL PLC 34.420 € (+0,61 %)     LVMH 513.600 € (+1,68 %)     ALTEN 57.450 € (+0,52 %)     AIR FRANCE -KLM 12.595 € (+0,12 %)     DASSAULT SYSTEMES 17.055 € (-0,15 %)     CAPITAL B 0.405 € (-10,29 %)     SOITEC 120.500 € (+3,43 %)     ADYEN 899.600 € (-0,46 %)     EUTELSAT COMMUNIC. 2.382 € (+0,29 %)     PUBLICIS GROUPE SA 89.260 € (+0,07 %)     RUBIS 33.160 € (+0,91 %)     NEXANS 161.300 € (+4,47 %)     MERSEN 42.760 € (-1,06 %)     J.MARTINS,SGPS 17.420 € (+0,17 %)     BAM GROEP KON 12.380 € (-0,88 %)     E PANGO 0.151 € (+6,34 %)  
News Réglementées
16/02/2023 15:25

Leading Operations Executive Adi Shemer Joins AppYea's Advisory Board

GAN YAVNE, ISRAEL / February 16, 2023 / AppYea Inc. (OTCQB:APYP), a developer of accurate wearable monitoring solutions to treat sleep apnea and snoring, is pleased to announce the addition of Adi Shemer to the advisory board of the Company, effective immediately.

Mr. Shemer brings extensive experience in senior operations, management and control of production processes, establishment, and management of logistics systems. Mr. Shemer established and managed marketing and distribution channels in the USA and Europe, mainly in the field of medical devices. Mr. Shemer has served in key senior executive roles including CEO at TR bike Ltd, CEO at Tzora Active Systems Ltd., and as Director of U.S. Operation at Moving Life Ltd. Mr. Shemer has a BSC degree in industrial and management engineering from Ariel University.

Mr. Shemer stated, "I am excited to join AppYea and look forward to playing an active role in helping enhance the production and distribution of DreamIT, which I believe will dramatically change the quality of sleep for millions of people across the world. I look forward to contributing my experience in the field of international distribution and logistics, as the company transitions from a development stage to fully commercial operations."

Boris (Bary) Molchadsky, Chairman and CEO of AppYea, further noted, "I am pleased to welcome Adi to the advisory board given his successful track record. I am convinced that Adi's experience will be invaluable as we advance our commercial strategy, including the development of new sales and distribution channels. The feedback from the market thus far has been extremely encouraging and we look forward to this next phase in our evolution."

About SleepX

SleepX is the research and development subsidiary of AppYea. The Company has developed a unique product for monitoring and treating sleep apnea and snoring. The technology is protected by several international patents. The Company currently focuses its activities on commercialization of its first product, DreamIT.

About AppYea

AppYea is a Healthtech company commercializing a breakthrough wearable technology for the treatment of snoring and developing wearable solutions to diagnose and treat sleep apnea. The company's solutions are based on its proprietary IP portfolio of AI and sensing technologies for the tracking and analysis of breathing patterns, vital signs and other physiological parameters during sleep, designed for greater accuracy at lower and affordable cost.​

Cautionary Note Regarding Forward-Looking Statements

Statements included in this press release, which are not historical in nature, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to the future performance of AppYea are subject to many factors including, but not limited to, the sufficiency or working capital and our ability to raise the capital needed to fund our development efforts, timing of product development, FDA approval/clearance of products in development, customer acceptance of our products in the market, the introduction of competitive products, the impact of any product liability or other adverse litigation, commercialization and technological difficulties, and the other risks identified in the S-1 resale registration statement filed with the Securities and Exchange Commission. Such statements are based upon the current beliefs and expectations of management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. The forward-looking statements contained in this press release are made as of the date hereof, and we do not undertake any obligation to update any forward-looking statements, whether as a result of future events, new information, or otherwise.

Contact:

Crescendo Communications, LLC
Tel: (212) 671-1020
Email: APYP@Crescendo-IR.com

SOURCE: AppYea Inc.



View source version on accesswire.com:
https://www.accesswire.com/739616/Leading-Operations-Executive-Adi-Shemer-Joins-AppYeas-Advisory-Board

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière